Literature DB >> 20105436

Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.

Christine Maric1, Carol Forsblom, Lena Thorn, Johan Wadén, Per-Henrik Groop.   

Abstract

Male sex is a risk factor for development and progression of diabetic nephropathy; however, the relationship between sex hormone levels and diabetic nephropathy in type 1 diabetic men is unknown. This was a prospective follow-up study as part of the nationwide Finnish Diabetic Nephropathy (FinnDiane) Study; 297 patients were followed for 5.9+/-1.5 years. Serum total testosterone (Tt) and estradiol (Te), calculated free testosterone (cFt) and estradiol (cFe) and sex hormone binding globulin were measured at baseline and correlated with urinary albumin excretion rate, estimated glomerular filtration rate and markers of metabolic syndrome. Diabetes without renal disease was associated with decreased Tt (p<0.001), Te (p<0.001) and cFt (p=0.001) levels compared with healthy non-diabetic men. With progression of renal disease from micro- to macroalbuminuria, this decrease in serum Tt was even more pronounced. Cox regression showed that cFt and cFe were independent predictors of the progression from macroalbuminuria to end-stage renal disease. Our study shows that men with type 1 diabetes exhibit dysregulated sex hormone levels, which is most pronounced in men with progressive renal disease, suggesting that sex hormones may play a role in the pathogenesis of diabetic nephropathy associated with type 1 diabetes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20105436      PMCID: PMC2891875          DOI: 10.1016/j.steroids.2010.01.011

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  34 in total

1.  Contrasting testosterone concentrations in type 1 and type 2 diabetes.

Authors:  Rashmi Tomar; Sandeep Dhindsa; Ajay Chaudhuri; Priya Mohanty; Rajesh Garg; Paresh Dandona
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

2.  Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.

Authors:  R K Stellato; H A Feldman; O Hamdy; E S Horton; J B McKinlay
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

3.  Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.

Authors:  M A Gall; P Hougaard; K Borch-Johnsen; H H Parving
Journal:  BMJ       Date:  1997-03-15

4.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

5.  Low serum testosterone concentration in middle-aged men with type 2 diabetes.

Authors:  Michiaki Fukui; Jintetsu Soh; Muhei Tanaka; Yoshihiro Kitagawa; Goji Hasegawa; Toshikazu Yoshikawa; Tsuneharu Miki; Naoto Nakamura
Journal:  Endocr J       Date:  2007-11-12       Impact factor: 2.349

6.  Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study.

Authors:  R Mangili; G Deferrari; U Di Mario; O Giampietro; R Navalesi; R Nosadini; G Rigamonti; R Spezia; G Crepaldi
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

7.  Mild Hypogonadotropic hypogonadism in obese men.

Authors:  G W Strain; B Zumoff; J Kream; J J Strain; R Deucher; R S Rosenfeld; J Levin; D K Fukushima
Journal:  Metabolism       Date:  1982-09       Impact factor: 8.694

8.  Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.

Authors:  Kim Pettersson-Fernholm; Matti K Karvonen; Jaana Kallio; Carol M Forsblom; Markku Koulu; Ullamari Pesonen; Johan A Fagerudd; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

9.  Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1992-11-15       Impact factor: 25.391

10.  Clinical factors associated with urinary albumin excretion in type II diabetes.

Authors:  S Savage; N J Nagel; R O Estacio; N Lukken; R W Schrier
Journal:  Am J Kidney Dis       Date:  1995-06       Impact factor: 8.860

View more
  22 in total

1.  Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.

Authors:  Michaele B Manigrasso; R Taylor Sawyer; Zachary M Hutchens; Elizabeth R Flynn; Christine Maric-Bilkan
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

2.  The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy.

Authors:  J N Harvey
Journal:  Diabetologia       Date:  2011-05-21       Impact factor: 10.122

3.  Diabetes alters aromatase enzyme levels in gonadal tissues of rats.

Authors:  N Burul-Bozkurt; C Pekiner; P Kelicen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-29       Impact factor: 3.000

4.  Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats.

Authors:  Michaele B Manigrasso; R Taylor Sawyer; David C Marbury; Elizabeth R Flynn; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-08

Review 5.  Podocytopathy in diabetes: a metabolic and endocrine disorder.

Authors:  Ana Diez-Sampedro; Oliver Lenz; Alessia Fornoni
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

6.  Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes.

Authors:  V Harjutsalo; C Maric; C Forsblom; L Thorn; J Wadén; P H Groop
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

Review 7.  Sugar, sex, and TGF-β in diabetic nephropathy.

Authors:  Maggie K Diamond-Stanic; Young H You; Kumar Sharma
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

Review 8.  Is the risk and nature of CVD the same in type 1 and type 2 diabetes?

Authors:  Lindsey Duca; Rachel Sippl; Janet K Snell-Bergeon
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

Review 9.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

Review 10.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.